CatalystEarnings

$CORT — CORCEPT THERAPEUTICS

CORT

$79.22

-3.31%

LLY

$1417.99

+0.61%

JNJ

$276.32

+3.81%

What changed

FQ2 FY2026 (ends Jun) | reported Jul 29: - Revenue: $256M - Adj EPS: $0.36 vs $0.05 🟢 Guidance (company): - FY2026 guidance, fiscal year ending Dec 31 revenue: $1.10B-$1.20B Also in play: $LLY $JNJ $ABBV $UNH $MRK

Why it matters

FQ2 FY2026 (ends Jun) | reported Jul 29:

Sources

pipeline